EP3801699A1 — Emergency devices
Assigned to DMK Pharmaceuticals Corp · Expires 2021-04-14 · 5y expired
What this patent protects
Described herein are syringe devices that can deliver a therapeutic dose of a pharmaceutical agent used to treat a drug or substance overdose. The therapeutic dose can be less than the amount of pharmaceutical agent in the syringe. The devices can also prevent device tampering by…
USPTO Abstract
Described herein are syringe devices that can deliver a therapeutic dose of a pharmaceutical agent used to treat a drug or substance overdose. The therapeutic dose can be less than the amount of pharmaceutical agent in the syringe. The devices can also prevent device tampering by a user and/or multiple uses of the same syringe device. Further, the syringe devices described herein can be used in a critical situation for delivery of an emergency and/or time sensitive pharmaceutical agent in response to a drug or substance overdose. The syringe devices can include a syringe that includes a dose of at least one pharmaceutical agent and can deliver a therapeutic dose of the pharmaceutical agent that can be less than the amount of pharmaceutical agent in the syringe. The syringe can also include a stopper and a gas bubble between the at least one pharmaceutical agent and the stopper.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.